Illuminaの資本の返還

Illuminaの資本の返還は何ですか。

Illumina, Inc.の資本の返還は-42.80%です。

資本の返還の定義は何ですか。

株主資本利益率は、株主資本の簿価との関係で事業の収益性の尺度です。これは、会計年度純利益を株主資本合計で除算することによって計算されます。

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Illuminaは何をしますか。

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.

Illuminaと類似の資本の返還

Bossini Internationalの資本の返還は-42.92%です。

Bharat Road Networkの資本の返還は-42.90%です。

Arcus Biosciences Incの資本の返還は-42.86%です。

Monarch Miningの資本の返還は-42.83%です。

Shandong Molong Petroleum Machineryの資本の返還は-42.82%です。

Galiano Goldの資本の返還は-42.81%です。

Illuminaの資本の返還は-42.80%です。

Hi-Level Technologyの資本の返還は-42.80%です。

Vimy Resourcesの資本の返還は-42.78%です。

Vimy Resourcesの資本の返還は-42.78%です。

Altan Rio Mineralsの資本の返還は-42.76%です。

U.S. Gold Corpの資本の返還は-42.73%です。

E Automotive Incの資本の返還は-42.72%です。